Rare diseases
Investigational molecules
Locations
Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis
NorwayStudy Comparing Teclistamab, Talquetamab, and Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Not Suitable for Stem Cell Transplant
NorwayStudy on Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NorwayStudy of Belantamab Mafodotin Alone and with Drug Combination for Patients with Relapsed/Refractory Multiple Myeloma
NorwayStudy on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis
NorwayStudy Comparing Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma
NorwayStudy on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
NorwayStudy on the Long-Term Safety of Nintedanib for Children and Adolescents with Interstitial Lung Disease
NorwayStudy Comparing Isatuximab with Carfilzomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant
NorwayStudy of Acalabrutinib and Rituximab for Elderly Patients with Untreated Mantle Cell Lymphoma
NorwayStudy Comparing Ripretinib and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors Previously Treated with Imatinib
NorwayStudy of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.
NorwayTell us about your condition – we search every trial in Europe and connect you with the right site.
